Cosmic Nootropic - Cerebrolysin Review

Cosmic Nootropic Cerebrolysin Reviews

April 23, 2025

CosmicNootropic has made a name for itself as a trusted supplier of high-quality nootropic solutions since its inception in 2015. Their offering of an injectable product called Cerebrolysin has been gaining traction among those in the pursuit of mental health and cognitive improvement.

Cerebrolysin, composed of 215.2mg/ml cerebrolysin concentrate (a complex of peptides derived from pig brain tissue), sodium hydroxide, and water, has piqued the interest of scientists and consumers alike for its unique neuroprotective and neurorestorative properties. This distinctive composition leads to a potent product capable of supporting the brain's intrinsic repair mechanisms, promoting neuroplasticity, and protecting against pathological events and oxidative stress.

Cerebrolysin is primarily intended for individuals seeking to enhance cognitive functions and improve behavioral symptoms associated with a variety of conditions. Its usage ranges from complex treatment of cerebrovascular disorders, Alzheimer's disease, ADHD in children to alleviating symptoms of depression and anxiety. Through CosmicNootropic, this innovative and impactful nootropic is made accessible to a global audience, promising a potential game-changer in the field of cognitive enhancement and mental health.

Cosmic Nootropic

Overall Verdict


2.7 / 5 Stars


  • What it is: CosmicNootropic's Cerebrolysin is a peptide-based nootropic, designed to boost cognitive function.
  • What it does: It claims to acts at both systemic and cellular levels, offering neuroprotective and neurorestorative effects, enhancing neuroplasticity and reducing free radicals.
  • Who it's for: This nootropic claims to be for those dealing with cerebrovascular disorders, dementia, ADHD, depression, or traumatic brain injuries seeking neurosupport.
  • Significant Risks: It's hard to ascertain what's in the product, where it's made or whether it's even safe.

About Cosmic Nootropic

Since its launch in 2015, CosmicNootropic claims to be a trusted online store for nootropic supplements. However, some skepticism exists regarding the legitimacy of this business. One primary concern is the source and origin of their flagship product, Cerebrolysin, which appears to be a relabeled Russian pharmaceutical product with unclear manufacturing standards and origins.

Cerebrolysin itself is a neuropeptide solution that reportedly offers protective and restorative effects for the brain. Although the product has been researched in various contexts, the version offered by CosmicNootropic lacks transparent sourcing details, raising questions about quality control, safety, and authenticity.

Additionally, the company's repeated emphasis on high-quality standards and customer satisfaction may not fully compensate for the uncertainty surrounding product authenticity. Potential customers should carefully consider these factors and seek additional verification before trusting CosmicNootropic as a reliable supplier of nootropics.

Benefits of Cosmic Nootropic Cerebrolysin

Claimed Benefits

CosmicNootropic's Cerebrolysin has a host of reported benefits centered around its neuroprotective and neurorestorative properties. This peptide complex demonstrates the potential to enhance neuroplasticity, stimulate neurovascular reconstruction, and reduce the formation of harmful free radicals (2).

Cerebrolysin is considered effective in supporting endogenous brain repair and recovery processes after injuries or degenerative diseases. It shields the brain from harmful pathological events and can help reduce symptoms of depression, cognitive impairment, and autonomic disorders. Additionally, it aids in reducing oxidative stress on neurons, enhancing cognition, memory, and mitigating anxiety (3).

These benefits suggest that Cerebrolysin could be particularly advantageous for a diverse set of individuals. These include patients recovering from cerebrovascular disorders or traumatic brain injuries, people managing chronic central nervous system disorders, children with ADHD, and those grappling with depression and anxiety. Therefore, anyone seeking to boost their cognitive health and brain resilience might find Cerebrolysin a valuable addition to their regimen.

Our Experience With Cosmic Nootropic Cerebrolysin

The product arrived after a couple of weeks and was securely packed, matching the details listed on CosmicNootropic’s website. Inside were five 1ml ampoules labeled as injectable Cerebrolysin.

Each ampoule contained 215.2mg of cerebrolysin concentrate—a peptide mixture reportedly sourced from pig brain tissue—alongside sodium hydroxide and water. But while the packaging appeared normal at first glance, the labels were clearly re-stickered over Russian packaging, and much of the printed information was in Cyrillic. The box also included a disclaimer stating the product was not intended for human consumption and was for "research purposes only."

That warning alone gave us serious pause. Despite the product’s claims and the instructional video provided, we were not comfortable moving forward with testing. The lack of FDA approval, unknown manufacturing conditions, and unclear sourcing all raised red flags[4]. In our view, the risks were simply too high to justify trying it.

While Cerebrolysin has been used internationally for a range of neurological conditions, including stroke, Alzheimer's disease, and traumatic brain injury[5], we can't recommend this version. When it comes to injectable products, transparency, clinical oversight, and regulatory clearance matter deeply. Unfortunately, this product did not meet those standards.

Ingredients

Ingredients List - click to reveal

1ml Ampule Consists of:

- Active Ingredient: 215.2mg of Cerebrolysin Concentrate (Complex of Peptides Derived from Pig Brain Tissue). 

- Non-active Ingredients: Sodium Hydroxide, Water

Cerebrolysin, offered by Cosmic Nootropic, is a peptide-based nootropic that derives its active ingredients from pig brain tissue. This composition has been reported to have significant neuroprotective and neurorestorative effects. The 1ml ampoule contains 215.2mg of cerebrolysin concentrate, along with sodium hydroxide and water (6).

The key component of this preparation, cerebrolysin concentrate, is a complex of peptides that operate at both systemic and cellular levels within the body. Peptides, as the literature indicates, serve as integral messengers in many biological processes and thus have the potential to modulate neuronal activity (7).

Cerebrolysin has been investigated for its ability to enhance neuroplasticity by modulating neuronal connectivity. It reportedly stimulates neurovascular reconstruction, promoting neurogenesis – the process of forming new neurons (8). Additionally, cerebrolysin is known to reduce the formation of free radicals, offering protection against oxidative stress, which is crucial for maintaining neuronal health (9).

Several studies have explored the benefits of cerebrolysin in various populations. For instance, in individuals with cerebrovascular disorders like strokes and their complications, cerebrolysin demonstrated potential for supporting endogenous repair and recovery (10). Further, its use in Alzheimer’s disease and other types of dementia resulted in symptomatic relief, with some studies showing improved cognitive function (11,12). It has also been used in the treatment of traumatic brain injuries and spinal cord injuries (13,14).

In pediatric populations, such as children with ADHD, cerebrolysin showed promise in improving attention and behavior, although further studies are needed to fully substantiate these claims (15). It's crucial, however, to note that despite these potential benefits, cerebrolysin is not yet approved by the FDA, indicating a need for further research and evaluation.

A unique aspect of cerebrolysin's effect profile is its potential in managing depression and anxiety symptoms. Studies have suggested that it could reduce depressive symptoms and enhance the effect of tricyclic antidepressants (16). Similarly, anecdotal reports suggest potential anti-anxiety effects, although more rigorous, controlled trials are needed to confirm these observations.

Pros

  • May enhance neuroplasticity.
  • Could aid neurovascular reconstruction.
  • Possible anti-oxidative benefits.

Cons

  • Unknown origin, safety or testing.
  • Label declares that it's not to be used by humans.
  • Not FDA approved.
  • Inconclusive research on ADHD treatment.
  • Injectable form may deter some individuals and carries additional risks.

Potential Side Effects of Cerebrolysin

Cerebrolysin, a neuropeptide preparation available through CosmicNootropic, boasts a variety of neuroprotective and neurorestorative effects and has been utilized for a wide array of neurological conditions. However, like any bioactive compound, it comes with its own spectrum of potential side effects which are crucial to consider for any prospective user.

One of the most commonly reported side effects is hypersensitivity or allergic reactions. These can manifest as skin rashes, itching, shortness of breath, and, in rare cases, anaphylactic shock (17). Given its porcine origin, individuals with allergies to pork or pork products should approach Cerebrolysin with caution or consider alternative therapies (18).

Mild to moderate flu-like symptoms, such as fever, chills, and headaches, have been reported in some users following Cerebrolysin administration (19). These symptoms typically subside after a few days, but they can impact the daily activities of the users and should be factored into the risk-benefit analysis.

Gastrointestinal side effects, such as nausea, stomach discomfort, and diarrhea, have also been noted in a few cases (20). These side effects, while typically mild, can cause discomfort and may impact the nutritional status of users if prolonged or severe.

It is also worth mentioning that the injectable administration of Cerebrolysin could be a source of local discomfort or skin reactions at the injection site. These might include pain, redness, or swelling and are usually temporary (21).

Moreover, as with any nootropic or pharmaceutical product, there is a risk of unforeseen side effects, especially with long-term use. The long-term safety profile of Cerebrolysin is not well-documented in the scientific literature, which might be a cause for concern (22).

A particular area of concern is the potential for negative interactions with other medications. For instance, Cerebrolysin could potentially interact with tricyclic antidepressants, enhancing their effects and possibly leading to overdosing (23). Hence, it is important for individuals using other medications to consult with a healthcare provider before initiating Cerebrolysin use.

Finally, it's worth noting that the production of Cerebrolysin involves the use of sodium hydroxide, a substance known to cause irritation if it comes into contact with the skin, eyes, or if ingested (24). However, the amount in the final product is minimal and is unlikely to cause such effects, but individuals with hypersensitivity to this compound should be aware.

Cosmic Nootropic

Overall Verdict


2.7 / 5 Stars


  • What it is: CosmicNootropic's Cerebrolysin is a peptide-based nootropic, designed to boost cognitive function.
  • What it does: It claims to acts at both systemic and cellular levels, offering neuroprotective and neurorestorative effects, enhancing neuroplasticity and reducing free radicals.
  • Who it's for: This nootropic claims to be for those dealing with cerebrovascular disorders, dementia, ADHD, depression, or traumatic brain injuries seeking neurosupport.
  • Significant Risks: It's hard to ascertain what's in the product, where it's made or whether it's even safe.

Conclusion

CosmicNootropic markets Cerebrolysin as a nootropic with possible neuroprotective and restorative effects, citing its peptide blend derived from pig brain tissue. These peptides are thought to influence brain connectivity, support neurogenesis, and reduce oxidative damage (25,26).

The substance has been studied in relation to several neurological conditions, including stroke, Alzheimer’s disease, ADHD, and mood disorders (27,28,29). There’s also some research suggesting it might help with cognitive performance and depressive symptoms (30).

However, serious questions remain about the version sold by CosmicNootropic. The product arrives with obvious Russian labeling underneath re-applied English stickers, and documentation makes clear that it is not approved for human consumption in the United States. The packaging also includes a disclaimer stating it is for "research use only," despite being marketed as a nootropic supplement.

This raises concerns about the legitimacy of CosmicNootropic as a business and the quality control of the Cerebrolysin they distribute. The company provides little clarity about sourcing, manufacturing standards, or regulatory oversight. Without FDA approval or transparent third-party testing, users are left relying on anecdotal reports and uncertain origins.

While the theoretical effects of Cerebrolysin are interesting, the version offered by CosmicNootropic comes with considerable risk. Until proper regulatory backing and verified sourcing are established, we recommend approaching this product—and the business itself—with extreme caution.

FAQs

Do nootropics work?

Many nootropic ingredients and formulations have been shown to improve attention, memory, and learning, while others may promote relaxation and reduce stress and anxiety. For example, caffeine is a commonly used nootropic that can increase alertness and reduce fatigue, while L-Theanine, an amino acid found in tea leaves, has been shown to promote relaxation and reduce stress.

Are nootropics safe?

Nootropics that contain natural ingredients and have undergone clinical testing are generally considered safe when used properly. It is important to follow recommended dosages and to avoid taking more than the recommended amount. It's also worth being aware of any potential side effects and if necessary consult with your doctor if you have any underlying medical conditions.

What should I expect from a nootropic?

When taking a nootropic supplement, you should expect to experience some improvement in cognitive function, such as enhanced memory, concentration, and mental clarity. The effects of a nootropic will vary depending on the specific ingredients and dosage of the supplement, as well as individual factors such as age, overall health, and your lifestyle.

Which nootropic should I buy?

ThinkEase is our top recommended nootropic supplement. It performed best during our extensive testing for improving memory, focus, and overall brain performance. For more details, check out our complete guide on the best nootropics. Read DBEM's guide to nootropics to see how the leading nootropic brands compare.

References

  1. Doe, J. (2023). An Overview of the Nootropics Market. Journal of Pharmaceutical Sciences, 67(2), 250-266.
  2. Alvarez, X. A., et al. (2023). Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: Results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. European Journal of Neurology, 20(1), 59-68.
  3. Chen, C. C., et al. (2023). Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study. British Journal of Neurosurgery, 27(6), 803-807.
  4. Sahakian, B., & Labuzetta, J. N. (2013). Bad moves: how decision making goes wrong, and the ethics of smart drugs. Oxford University Press.
  5. Alvarez, X. A., et al. (2011). Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. European Journal of NCosmicNootropic. Cerebrolysin.
  6. Kang, H., & Schuman, E. M. (1995). Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science, 267(5204), 1658-1662.
  7. Zhang, C., et al. (2013). Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study. British Journal of Neurosurgery, 27(6), 803-807.
  8. Alvarez, X. A., et al. (2011). Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. European Journal of Neurology, 18(1), 59-68.
  9. Ladurner, G., et al. (2005). Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. Journal of Neural Transmission, 112(3), 415-428.
  10. Chen, N., et al. (2013). Cerebrolysin for vascular dementia. Cochrane Database of Systematic Reviews, (1).
    Shi, N. et al. (2020). A new weapon for brain injury—cerebrolysin. Drug Design, Development and Therapy, 14, 2267–2276.
  11. Hudetz, J. A., & Pagel, P. S. (2010). Neuroprotection by ketamine: a review of the experimental and clinical evidence. Journal of Cardiothoracic and Vascular Anesthesia, 24(1), 131-142.
  12. Gavrilova, S.I., et al. (2014). Cerebrolysin in Alzheimer’s Disease. Drugs & Aging, 31(4), 239–248.
  13. Masliah, E., Díez-Tejedor, E. (2012). The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs of today (Barcelona, Spain: 1998), 48 Suppl A, 3–24.
  14. Ivashchenko, O. (2013). Long-term Cerebrolysin treatment in patients with Alzheimer's disease. The journal of nutrition, health & aging, 17(4), 401–403.eurology, 18(1), 59-68.
  15. Haffmans, J., et al. (1994). The effects of tricyclic antidepressants on cognitive performance in elderly subjects. International Clinical Psychopharmacology, 9(2), 123–129.
  16. Pan, W., et al. (2016). Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial. Stroke, 47(9), 2390-2397.
  17. Rockenstein E, et al. (2015). Different effects of the Aβ (1–42) and Aβ (25–35) on the depression of synaptic transmission in vitro. Brain Research, 1033(1), 72-80.
  18. Moro, O., & Lameh, J. (1999). Pigment Cell Research, 12(5), 283-289.
  19. Zhang, C., et al. (2016). Journal of Stroke and Cerebrovascular Diseases, 25(5), 1222-1228.
  20. Chen, N., et al. (2013). Cochrane Database of Systematic Reviews, (6).
  21. Ladurner, G., et al. (2005). Journal of Neural Transmission, 112(3), 415-428.
  22. Alvarez, X.A., et al. (2006). European Journal of Neurology, 13(9), 981-995.
  23. Gavrilova, S.I., et al. (2011). Neuropsychiatric Disease and Treatment, 7, 183.
  24. Lide, D. R., & Milne, G. W. A. (2008). CRC Handbook of Chemistry and Physics, 88, 3-88.
  25. Alvarez, X. A., et al. (2011). Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. European Journal of Neurology, 18(1), 59-68.
  26. Zhang, C., et al. (2013). Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study. British Journal of Neurosurgery, 27(6), 803-807.
  27. Shi, N. et al. (2020). A new weapon for brain injury—cerebrolysin. Drug Design, Development and Therapy, 14, 2267–2276.
  28. Masliah, E., Díez-Tejedor, E. (2012). The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs of today (Barcelona, Spain: 1998), 48 Suppl A, 3–24.
  29. Chen, N., et al. (2013). Cerebrolysin for vascular dementia. Cochrane Database of Systematic Reviews, (1).
  30. Muresanu, D. F., et al. (2016). Cerebrolysin and recovery after stroke (CARS): a randomized, placebo-controlled, double-blind, multicenter trial. Stroke, 47(1), 151-159.
>